Introduction As more individuals seek effective solutions for weight management and diabetes control, GLP-1 (glucagon-like peptide-1) drugs have emerged as a popular option. These injectable medications, including liraglutide (Saxenda, Victoza) and semaglutide (Ozempic, Wegovy), simulate the effects

Introduction In recent years, GLP-1 (glucagon-like peptide-1) medications have gained significant attention for their ability to aid in weight loss. Originally designed for managing type 2 diabetes, these drugs have showcased the potential for weight loss, making

In recent years, the role of medication in weight loss has gained significant attention, with Semaglutide leading the charge. Originally developed for managing type 2 diabetes, this GLP-1 receptor agonist has shown remarkable efficacy in promoting weight